Our expertise spans ten key categories: diagnostics, oncology, rare diseases, women’s health, neurology, infectious diseases, inflammatory diseases, cardiometabolic diseases, biosimilars, and “others.” In addition, some of our priorities, such as Precision Medicine and Biosimilars, intersect multiple categories.
Today, we invite you to take a journey back in time with us to revisit some of our pivotal projects in the fields of Precision Medicine and Biosimilars.
AHF IN PRECISION MEDICINE
- BRAF-Mutated Melanoma Journey in Latin America: Expert Recommendations From Diagnosis to Treatment
- BRAF Testing in Melanoma and Colorectal Cancer in Latin America: Challenges and Opportunities
- Expert Recommendations for the Diagnosis, Treatment, and Management of Adult B-Cell Acute Lymphoblastic Leukemia in Latin America
- Opportunities and challenges for newborn screening and early diagnosis of rare diseases in Latin America
- Adopting Molecular Testing for Solid Tumors in Latin America: Challenges and Opportunities
- Challenges and recommendations to increasing the use of exome sequencing and whole genome sequencing for diagnosing rare diseases in Brazil: an expert perspective
- Challenges and Opportunities to Access Innovation in Latin America: The Case of Combination Therapies for Multiple Myeloma
- Raising Awareness and Increasing Access to Next-Generation Sequencing in Oncology in Brazil
- Expanding KRAS Gene Testing: We’re Ready and Here’s Why
- Brazilian Healthcare Policy for Targeted Oncology Therapies and Companion Diagnostics
AHF IN BIOSIMILARS
- Recommendations for the regulation of biosimilars and their implementation in Latin America
- Recommendations on how to ensure the safety and effectiveness of biosimilars in Latin America: a point of view
- Streamlining breast cancer and colorectal cancer biosimilar regulations to improve treatment access in Latin America: an expert panel perspective
- Recommendations for Interchangeability in a Growing Biosimilar Market in Latin America
Rare diseases have been a key priority for AHF. Demonstrating our commitment to improving the landscape of rare diseases in Latin America, we conducted the First Congress on Rare Diseases for Latin America and the Caribbean in 2023. This year, on October 16-17 in Bogotá, Colombia, we will hold the Second Congress on Rare Diseases for Latin America and the Caribbean. This event, led by AHF and co-hosted by ERCAL, FECOER, and Pontificia Universidad Javeriana, aims to build upon the inaugural event by taking a solution-focused approach to bridging gaps in rare disease care in Latin America.
Diego Gil, President of ERCAL and FECOER, invites you to join us at this event:
“For two days we will meet to share the latest advances in research, diagnosis, treatment and access to rare diseases. Join us in Bogotá and be part of the change we are building to improve the outlook for those living with rare diseases in our region!”
– Diego Gil Cardoso, President of ERCAL and FECOER
THE AHF LEADERSHIP ALLIANCE: Prioritizing Stakeholder Engagement and Collaboration
The AHF Leadership Alliance is a membership-based program for companies that share our mission to increase and improve access to innovative health, nutrition, and wellness technologies and services throughout the Americas and the Caribbean. The Leadership Alliance provides a forum for members to contribute to the development of advocacy for health policy priorities, legislative and regulatory initiatives, and best practices that advance access, innovation, and research for national and regional stakeholders.
Members of the Leadership Alliance play an essential role in informing and co-creating programming and thought-leadership initiatives that underscore key priorities. Members also participate in guided interactions with academic, medical, and scientific societies, as well as patient advocacy groups and health ministries.
The Leadership Alliance provides a unique forum that engages the private and public sector together to educate, advocate and accelerate access for innovative solutions in healthcare, nutrition, and wellness. As a trusted voice in the Americas and the Caribbean, AHF facilitates science-driven dialogues and programming with the public sector that results in access to important technologies in individual and regional markets.
By Providing Members with:
- Biannual meetings
- Quarterly Newsletter
- Networking and Engagement Opportunities
- Corporate Branding and Recognition
- Publication Contributions
- Stakeholder Meetings
- Program Hosting
- Ad Hoc Working Groups
- News and Advocacy Alerts
- Sharing Best Practices
The AHF Leadership Alliance:
- Demonstrates your company’s commitment to healthcare and community access.
- Helps stimulate new emerging markets in neighboring countries.
- Provides the steppingstones to national consensus documents, which identify your company to country leaders as the go-to for specific healthcare needs.
- Enlarges market access to your products by providing education to consumers and country leaders in an independent format.
COMING SOON
Vaccines Beat
Given the central importance of vaccines in public health discussions, under the guidance of Chief Editors Dr. Enrique Chacon-Cruz and Dr. Javier Casellas, Vaccines Beat is dedicated to providing curated, timely, relevant, and accessible information on all vaccine-preventable diseases.
Who We Are
- A global newsletter offering a comprehensive 360-degree perspective
- Featuring monthly updates, expert commentaries, and recommendations from leading vaccine experts
- Building a robust network of stakeholders in the vaccine community
VACCINES BEAT – SUBSCRIBE HERE
AHF remains steadfast in our mission to improve healthcare and healthcare access through medical education and policy-driven evidence-based initiatives. We look forward to your continued support and partnership as we work together to bridge gaps in healthcare across Latin America and beyond.
To support AHF or learn more, please contact our director of marketing communications: tvidal@the-ahf.org
